Hydration is key and can help prevent nausea, constipation, and dehydration
Conclusion A new drug named tirzepatide has been approved to treat T2DM, and it is expected to be approved for weight loss by activating both GLP-1 and GIP receptors through a unique mechanism
Chronic stress elevates cortisol and inflammatory markers that worsen cardiovascular risk
Nausea, vomiting, diarrhea, and constipation were all more common at higher doses, though these effects typically diminished after the body adapted to each new dose level
Identification of therapeutic effect of glucagon-like peptide 1 in the treatment of STZ-induced diabetes mellitus in rats by restoring the balance of intestinal flora
Phase I study of green tea extract in patients with advanced lung cancer